INCY analyst estimates
Incyte (INCY) analyst ratings, the average price target and its range, and every firm's latest call.
INCY analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 30, 2026 | Oppenheimer | Oppenheimer Upgrades Incyte (INCY) to Outperform | $144.00 |
| Oct 30, 2026 | UBS | H.C. Wainwright Reiterates Buy Rating on Incyte (INCY) | $152.00 |
| Oct 27, 2026 | Oppenheimer | H.C. Wainwright Reiterates Buy Rating on Incyte (INCY) | $152.00 |
| Oct 16, 2026 | Raymond James | H.C. Wainwright Reiterates Buy Rating on Incyte (INCY) | $152.00 |
| Oct 14, 2026 | Truist Financial | Incyte price target raised to $115 from $105 at Truist | $115.00 |
| Oct 8, 2026 | RBC Capital | Incyte price target raised to $114 from $109 at RBC Capital | $114.00 |
| Oct 5, 2026 | Stifel Nicolaus | Incyte (INCY) PT Raised to $157 at Stifel | $157.00 |
| Oct 5, 2026 | UBS | Incyte (INCY) PT Raised to $127 at UBS, Neutral Rating Maintained | $127.00 |
| Sep 28, 2026 | H.C. Wainwright | Incyte (INCY) PT Raised to $152 at H.C. Wainwright | $152.00 |
| Aug 20, 2026 | Canaccord Genuity | Incyte initiated with a Buy at Canaccord | $152.00 |
| Aug 17, 2026 | Piper Sandler | Incyte price target raised to $130 from $110 at Piper Sandler | $130.00 |
| Aug 13, 2026 | Bernstein | Incyte price target raised to $104 from $99 at Bernstein | $104.00 |
| Aug 3, 2026 | Leerink Partners | Incyte price target raised to $155 from $131 at Leerink | $155.00 |
| Jul 29, 2026 | BMO Capital | Incyte price target raised to $130 from $112 at BMO Capital | $130.00 |
| Jul 29, 2026 | RBC Capital | Incyte price target raised to $109 from $99 at RBC Capital | $109.00 |
- 20 firms rate INCY: 10 buy, 10 hold, 0 sell.
- The average price target is $138.08 from 12 analysts, from $104.00 to $157.00.
Updated 2026-11-02 23:11 UTC